Your email has been successfully added to our mailing list.

×
0 0 0 0.00601534951254924 0.0163866417755652 0.00394109105994591 2.07425845259836E-05 -0.0250777846919728
Stock impact report

Interpace Q1 revenue +53%, shares -7.5% [Seeking Alpha]

INTERPACE BIOSCIENCES INC (IDXG) 
Last interpace biosciences inc earnings: 11/13 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: interpacediagnostics.com/investors
Company Research Source: Seeking Alpha
Interpace Diagnostics (IDXG-7.5%Q1 resultsRevenue up 53% to $9.2M, which did not include Pharma services revenues.Gross profitdeclined 2,200 bpsAdj. EBITDA was $(4.1)M as compared to $(1.8)M Y/Y.Net loss: ($9.3M), loss/share: ($2.31).Cash and equivalents at quarter-end: ~$13.7M.Q2 guidanceIn response to customer interest the company is developing serology antibody ELISA testing for COVID-19 at our CLIA lab.Previously:Interpace Biosciences EPS misses by $1.07, beats on revenue Show less Read more
Impact Snapshot
Event Time:
IDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IDXG alerts
Opt-in for
IDXG alerts

from News Quantified
Opt-in for
IDXG alerts

from News Quantified